Joint separation: Cooperation will extend service offerings of LANXESS subsidiary
Saltigo GmbH, the specialist in custom synthesis based in Langenfeld, Germany, and Reuter Chemische Apparatebau KG (RCA) of Freiburg, Germany, concluded a cooperation agreement on October 1. The companies will jointly develop processes for the synthesis of active pharmaceutical ingredients and intermediates. "In the last few years, we have successfully cooperated on a large number of projects in the field of separation technology for the production of chiral, enantiomerically pure substances. We have now raised our long-time business relationship to a new level," says Dr. Andreas Stolle, head of the Pharma business line at Saltigo.
RCA produces high-grade chiral substances, and also has innovative, patented technologies for racemate separation. With Saltigo's experience in working with complex molecules and Challenging Chemistry and RCA's know-how in the field of chiral separation, economical separation processes can be identified for a given racemate. The cooperation will support Saltigo's focus on innovative cost optimization programs as part of the Contract Manufacturing business model. "Sustainable process improvements leading to reduced costs will generate added value for our customers," says Stolle. By selecting suitable separation technology and additionally optimizing the subsequent synthesis chain, it was possible, for example, to significantly lower the production costs for commercial quantities of an active pharmaceutical ingredient compared to the original forecast.
Most read news
Other news from the department business & finance
These products might interest you

AZURA Purifier + LH 2.1 by KNAUER
Preparative Liquid Chromatography - New platform for more throughput
Save time and improve reproducibility during purification

Pharmaceutical Substances by Thieme Verlag
Look up Industrial Syntheses of 2,600 APIs
Your tool for Syntheses, Patents and Applications – Pharmaceutical Substances

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Synthesis
Chemical synthesis is at the heart of modern chemistry and enables the targeted production of molecules with specific properties. By combining starting materials in defined reaction conditions, chemists can create a wide range of compounds, from simple molecules to complex active ingredients.

Topic world Synthesis
Chemical synthesis is at the heart of modern chemistry and enables the targeted production of molecules with specific properties. By combining starting materials in defined reaction conditions, chemists can create a wide range of compounds, from simple molecules to complex active ingredients.